Runnymede Capital Advisors Inc. Acquires 4,837 Shares in ResMed Inc.

The firm added to its stake in the medical equipment provider during the fourth quarter.

Apr. 6, 2026 at 10:55am

Got story updates? Submit your updates here. ›

Runnymede Capital Advisors Inc. acquired a new stake of 4,837 shares in ResMed Inc. (NYSE:RMD) during the fourth quarter, according to a recent SEC filing. The firm's new position in the medical equipment provider's stock was valued at approximately $1,165,000.

Why it matters

This acquisition by Runnymede Capital Advisors represents an institutional investor's increased confidence in ResMed's business and growth prospects. As a leading provider of sleep apnea and respiratory care devices, ResMed's performance is closely watched by the investment community.

The details

Runnymede Capital Advisors Inc. added the 4,837 shares of ResMed to its portfolio in the fourth quarter. ResMed is a global medical device company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions. The company develops and distributes a range of CPAP and other sleep therapy equipment.

  • Runnymede Capital Advisors Inc. acquired the 4,837 ResMed shares during the fourth quarter of 2025.

The players

Runnymede Capital Advisors Inc.

An investment management firm that acquired a new stake in ResMed Inc. during the fourth quarter.

ResMed Inc.

A global medical device company that develops and distributes sleep apnea and respiratory care equipment.

Got photos? Submit your photos here. ›

The takeaway

This acquisition by Runnymede Capital Advisors reflects continued institutional investor interest in ResMed's market-leading position in the sleep therapy and respiratory care device industry. As the company navigates industry trends and regulatory changes, its stock performance will likely remain a focus for analysts and investors.